HK1148999A1 - The process for preparing benzazepine compounds or salts thereof - Google Patents

The process for preparing benzazepine compounds or salts thereof

Info

Publication number
HK1148999A1
HK1148999A1 HK11103250.6A HK11103250A HK1148999A1 HK 1148999 A1 HK1148999 A1 HK 1148999A1 HK 11103250 A HK11103250 A HK 11103250A HK 1148999 A1 HK1148999 A1 HK 1148999A1
Authority
HK
Hong Kong
Prior art keywords
salts
preparing
compounds
benzazepine compounds
benzazepine
Prior art date
Application number
HK11103250.6A
Other languages
English (en)
Inventor
Yasuhiro Torisawa
Kaoru Abe
Yasuaki Muguruma
Shigekazu Fujita
Hidenori Ogawa
Naoto Utsumi
Masahiro Miyake
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37398782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1148999(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1148999A1 publication Critical patent/HK1148999A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK11103250.6A 2005-09-02 2009-02-11 The process for preparing benzazepine compounds or salts thereof HK1148999A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005254744 2005-09-02
HK09101266.6A HK1124318A1 (en) 2005-09-02 2009-02-11 Process for preparing benzazepine compounds or salts thereof

Publications (1)

Publication Number Publication Date
HK1148999A1 true HK1148999A1 (en) 2011-09-23

Family

ID=37398782

Family Applications (5)

Application Number Title Priority Date Filing Date
HK09101266.6A HK1124318A1 (en) 2005-09-02 2009-02-11 Process for preparing benzazepine compounds or salts thereof
HK11103250.6A HK1148999A1 (en) 2005-09-02 2009-02-11 The process for preparing benzazepine compounds or salts thereof
HK10111584.7A HK1144932A1 (en) 2005-09-02 2010-12-13 Process for preparing derivatives of benzoic acid
HK11100027.4A HK1145835A1 (zh) 2005-09-02 2011-01-04 製備苯並氮雜卓化合物或其鹽的方法
HK12113121.1A HK1172329A1 (zh) 2005-09-02 2012-12-19 製備苯並氮雜䓬化合物或其鹽的方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09101266.6A HK1124318A1 (en) 2005-09-02 2009-02-11 Process for preparing benzazepine compounds or salts thereof

Family Applications After (3)

Application Number Title Priority Date Filing Date
HK10111584.7A HK1144932A1 (en) 2005-09-02 2010-12-13 Process for preparing derivatives of benzoic acid
HK11100027.4A HK1145835A1 (zh) 2005-09-02 2011-01-04 製備苯並氮雜卓化合物或其鹽的方法
HK12113121.1A HK1172329A1 (zh) 2005-09-02 2012-12-19 製備苯並氮雜䓬化合物或其鹽的方法

Country Status (16)

Country Link
US (2) US8273735B2 (zh)
EP (3) EP2261215B1 (zh)
JP (6) JP5046587B2 (zh)
KR (4) KR20100132087A (zh)
CN (4) CN102746229B (zh)
AT (2) ATE544744T1 (zh)
CY (3) CY1111788T1 (zh)
DE (1) DE602006019882D1 (zh)
DK (3) DK1919874T3 (zh)
ES (3) ES2358217T3 (zh)
HK (5) HK1124318A1 (zh)
IL (5) IL189481A (zh)
PL (3) PL1919874T3 (zh)
PT (3) PT1919874E (zh)
SI (3) SI2261215T1 (zh)
WO (1) WO2007026971A2 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100132087A (ko) * 2005-09-02 2010-12-16 오츠카 세이야쿠 가부시키가이샤 벤즈아제핀 화합물 또는 그의 염의 제조 방법
JP2009035513A (ja) * 2007-08-02 2009-02-19 Ube Ind Ltd ４−ｎ−（メチルベンゾイル）アミノ−２−メチル安息香酸の製法
CN102020609A (zh) * 2009-09-17 2011-04-20 北京本草天源药物研究院 托伐普坦晶体或无定形物及其制备方法
CN101817783B (zh) * 2010-05-12 2012-02-22 天津泰普药品科技发展有限公司 一种托伐普坦中间体的制备方法
US9024015B2 (en) 2010-10-05 2015-05-05 Hetero Research Foundation Process for preparing tolvaptan intermediates
CN102093247B (zh) * 2010-12-15 2014-03-12 天津药物研究院 一种2-甲基-4-n-(2-甲基苯甲酰)苯甲酸的制备方法
CN102060769B (zh) * 2010-12-20 2013-09-18 天津药物研究院 一种托伐普坦的制备方法
CN102093293B (zh) * 2011-03-02 2012-06-13 宁波人健药业集团有限公司 一种制备7-氯-2,3,4,5-四氢-1h-1-苯并氮杂卓-5-酮的方法
CN102558051B (zh) * 2011-07-15 2016-08-10 天津泰普药品科技发展有限公司 一种托伐普坦晶体及其药物组合物
CN102382053B (zh) * 2011-08-31 2016-06-01 浙江华海药业股份有限公司 一种制备托伐普坦中间体的方法
CN102329268B (zh) * 2011-10-25 2014-03-12 天津药物研究院 7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN103159641A (zh) * 2011-12-14 2013-06-19 天津泰普药品科技发展有限公司 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法
CN102690211B (zh) * 2012-06-05 2015-12-09 郑州明泽医药科技有限公司 托伐普坦中间体的制备方法
CN103012266B (zh) * 2012-11-23 2014-07-23 天津药物研究院 一种7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN103012265B (zh) * 2012-11-23 2014-10-15 天津药物研究院 一种7-氯-5-氧代-2,3,4,5-四氢-1h-1-苯并氮杂卓的制备方法
CN104418803A (zh) * 2013-08-21 2015-03-18 上海天慈生物谷生物工程有限公司 一种托伐普坦的制备方法
IN2013MU03296A (zh) 2013-10-21 2015-07-17 Rpg Life Sciences Ltd
CN103880747B (zh) * 2014-03-20 2015-08-26 成都百裕科技制药有限公司 无定形托伐普坦的制备方法
CN106883175A (zh) * 2015-12-16 2017-06-23 天津泰普制药有限公司 一种托伐普坦的制备方法
ITUB20160256A1 (it) * 2016-01-15 2017-07-15 Olon Spa Derivati idrossibenzazepinici esterificati e loro impiego nella sintesi di tolvaptan
CN107663171A (zh) * 2017-10-10 2018-02-06 常州市阳光药业有限公司 高纯度托伐普坦的制备方法
CN113004202B (zh) * 2019-12-20 2023-10-24 成都倍特药业股份有限公司 一种高纯度托伐普坦的制备方法
CN113717070A (zh) * 2020-05-25 2021-11-30 南京正大天晴制药有限公司 一种升压素v2受体拮抗剂的中间体的制备方法
WO2022256378A1 (en) 2021-06-02 2022-12-08 Esperion Therapeutics, Inc. Compositions containing and therapies using bempedoic acid and tolvaptan

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965144A (en) * 1973-08-13 1976-06-22 Syva Company Carbanilate compound for erythemal protection
DE2412855C2 (de) * 1974-03-18 1983-03-31 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Carbonsäuren
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
CA1255327A (en) * 1984-07-24 1989-06-06 Celanese Corporation Process for producing acyloxy aromatic carboxylic acid
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
EP0450097B1 (en) 1989-10-20 1996-04-24 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
JP2927513B2 (ja) * 1990-07-05 1999-07-28 科学技術振興事業団 四級ピリジニウム化合物
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) * 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
EP0650966A1 (de) * 1993-10-28 1995-05-03 F. Hoffmann-La Roche Ag Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates
JPH07154765A (ja) * 1993-11-29 1995-06-16 Hitachi Ltd 画像通信端末
JPH09168396A (ja) 1995-10-19 1997-06-30 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシ−２，３，４，５−テトラヒドロ−１ｈ−ベンゾアゼピン誘導体の製造方法
ZA9610853B (en) * 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
DE19617558A1 (de) * 1996-05-02 1997-11-06 Hoechst Ag Verfahren zur Herstellung von 4,5-Dichlor-2-methylbenzoesäure
US5710299A (en) * 1996-06-27 1998-01-20 Albemarle Corporation Production of bridged metallocene complexes and intermediates therefor
WO1998024667A1 (de) * 1996-12-02 1998-06-11 Robert Bosch Gmbh Verfahren und vorrichtung zur einstellung der bremswirkung bei einem fahrzeug
JPH10182681A (ja) * 1996-12-27 1998-07-07 Nippon Petrochem Co Ltd ビスアルキルシクロペンタジエニル錯体化合物の製造法
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US7022699B2 (en) * 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
GB0111566D0 (en) * 2001-05-11 2001-07-04 Portela & Ca Sa Method for preparation of (s)-(+)-and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azephine-5-carboxamide
KR20100132087A (ko) * 2005-09-02 2010-12-16 오츠카 세이야쿠 가부시키가이샤 벤즈아제핀 화합물 또는 그의 염의 제조 방법
JP2009035513A (ja) * 2007-08-02 2009-02-19 Ube Ind Ltd ４−ｎ−（メチルベンゾイル）アミノ−２−メチル安息香酸の製法

Also Published As

Publication number Publication date
EP2261215A1 (en) 2010-12-15
JP2012176979A (ja) 2012-09-13
JP2012197296A (ja) 2012-10-18
JP5784164B2 (ja) 2015-09-24
SI2251319T1 (sl) 2012-05-31
KR20110029184A (ko) 2011-03-22
US8501730B2 (en) 2013-08-06
IL217446A0 (en) 2012-02-29
CN101967107B (zh) 2012-12-12
CN101273017A (zh) 2008-09-24
DE602006019882D1 (de) 2011-03-10
SI2261215T1 (sl) 2015-02-27
CN102746229A (zh) 2012-10-24
CY1116082T1 (el) 2017-02-08
IL189481A0 (en) 2008-08-07
PL2261215T3 (pl) 2015-06-30
JP2014205699A (ja) 2014-10-30
ATE544744T1 (de) 2012-02-15
KR101119732B1 (ko) 2012-03-22
EP2251319A2 (en) 2010-11-17
IL217445A (en) 2013-11-28
KR20100132087A (ko) 2010-12-16
ATE496895T1 (de) 2011-02-15
JP5893083B2 (ja) 2016-03-23
PT1919874E (pt) 2011-03-14
JP2012197295A (ja) 2012-10-18
DK1919874T3 (da) 2011-02-21
US20090306369A1 (en) 2009-12-10
EP2251319B1 (en) 2012-02-08
CN101967107A (zh) 2011-02-09
EP2251319A3 (en) 2011-03-09
IL189481A (en) 2013-08-29
PT2251319E (pt) 2012-03-05
CN101273017B (zh) 2011-09-14
DK2251319T3 (da) 2012-03-05
WO2007026971A2 (en) 2007-03-08
HK1144932A1 (en) 2011-03-18
US20120226034A1 (en) 2012-09-06
KR101077329B1 (ko) 2011-10-26
ES2379153T3 (es) 2012-04-23
EP1919874A2 (en) 2008-05-14
HK1124318A1 (en) 2009-07-10
IL217445A0 (en) 2012-02-29
WO2007026971A3 (en) 2007-07-05
IL217446A (en) 2016-08-31
EP2261215B1 (en) 2014-12-31
PL2251319T3 (pl) 2012-07-31
JP2007091738A (ja) 2007-04-12
CY1111788T1 (el) 2015-10-07
KR20080039459A (ko) 2008-05-07
CN102746229B (zh) 2015-04-08
IL217444A (en) 2013-05-30
ES2358217T3 (es) 2011-05-06
KR20100133028A (ko) 2010-12-20
PL1919874T3 (pl) 2011-06-30
IL222396A (en) 2014-05-28
ES2527794T3 (es) 2015-01-29
DK2261215T3 (en) 2015-02-02
JP5583172B2 (ja) 2014-09-03
CY1112496T1 (el) 2015-12-09
EP1919874B1 (en) 2011-01-26
CN102219741B (zh) 2013-05-15
PT2261215E (pt) 2015-02-13
CN102219741A (zh) 2011-10-19
HK1145835A1 (zh) 2011-05-06
KR101019363B1 (ko) 2011-03-07
IL217444A0 (en) 2012-02-29
JP5046587B2 (ja) 2012-10-10
US8273735B2 (en) 2012-09-25
HK1172329A1 (zh) 2013-04-19
JP2014139203A (ja) 2014-07-31
SI1919874T1 (sl) 2011-04-29

Similar Documents

Publication Publication Date Title
HK1172329A1 (zh) 製備苯並氮雜䓬化合物或其鹽的方法
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
HUS1600009I1 (hu) Nitrogéntartalmú aromás származékok és ezeket tartalmazó gyógyászati készítmények
ZA200604719B (en) DPP-IV inhibitors
HK1157334A1 (zh) -氯- -甲基- -四氫- -苯並氮雜卓鹽酸半水的製造步驟
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
HK1076816A1 (zh)
HK1064673A1 (en) Fused-polycyclic compounds
MY141657A (en) Novel intermediate for the preparation of therapeutically active imidazopyridines